TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT06359041: RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

Sponsor: Cabaletta Bio · Phase: PHASE1/PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 24 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$1,693,200

Rescue Site Savings

+$1,128,800

Unlock Full NCT06359041 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06359041 Rescue Dossier →